Pulmonx Statistics
Total Valuation
Pulmonx has a market cap or net worth of $258.68 million. The enterprise value is $226.40 million.
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025, after market close.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pulmonx has 39.80 million shares outstanding. The number of shares has increased by 2.99% in one year.
| Current Share Class | 39.80M |
| Shares Outstanding | 39.80M |
| Shares Change (YoY) | +2.99% |
| Shares Change (QoQ) | +0.78% |
| Owned by Insiders (%) | 4.19% |
| Owned by Institutions (%) | 90.69% |
| Float | 38.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.18 |
| Forward PS | 2.74 |
| PB Ratio | 3.16 |
| P/TBV Ratio | 3.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.58, with a Debt / Equity ratio of 0.66.
| Current Ratio | 5.58 |
| Quick Ratio | 4.72 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.96 |
Financial Efficiency
Return on equity (ROE) is -55.25% and return on invested capital (ROIC) is -23.17%.
| Return on Equity (ROE) | -55.25% |
| Return on Assets (ROA) | -20.55% |
| Return on Invested Capital (ROIC) | -23.17% |
| Return on Capital Employed (ROCE) | -40.45% |
| Revenue Per Employee | $287,935 |
| Profits Per Employee | -$193,794 |
| Employee Count | 291 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.29 |
Taxes
In the past 12 months, Pulmonx has paid $500,000 in taxes.
| Income Tax | 500,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.14% in the last 52 weeks. The beta is 0.51, so Pulmonx's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -25.14% |
| 50-Day Moving Average | 7.16 |
| 200-Day Moving Average | 6.91 |
| Relative Strength Index (RSI) | 40.99 |
| Average Volume (20 Days) | 267,392 |
Short Selling Information
The latest short interest is 1.17 million, so 2.93% of the outstanding shares have been sold short.
| Short Interest | 1.17M |
| Short Previous Month | 1.25M |
| Short % of Shares Out | 2.93% |
| Short % of Float | 3.06% |
| Short Ratio (days to cover) | 2.36 |
Income Statement
In the last 12 months, Pulmonx had revenue of $83.79 million and -$56.39 million in losses. Loss per share was -$1.44.
| Revenue | 83.79M |
| Gross Profit | 62.00M |
| Operating Income | -55.99M |
| Pretax Income | -57.29M |
| Net Income | -56.39M |
| EBITDA | -54.49M |
| EBIT | -55.99M |
| Loss Per Share | -$1.44 |
Full Income StatementBalance Sheet
The company has $101.48 million in cash and $56.47 million in debt, giving a net cash position of $45.01 million or $1.13 per share.
| Cash & Cash Equivalents | 101.48M |
| Total Debt | 56.47M |
| Net Cash | 45.01M |
| Net Cash Per Share | $1.13 |
| Equity (Book Value) | 85.81M |
| Book Value Per Share | 2.16 |
| Working Capital | 111.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$31.54 million and capital expenditures -$1.45 million, giving a free cash flow of -$32.98 million.
| Operating Cash Flow | -31.54M |
| Capital Expenditures | -1.45M |
| Free Cash Flow | -32.98M |
| FCF Per Share | -$0.83 |
Full Cash Flow StatementMargins
Gross margin is 74.00%, with operating and profit margins of -66.82% and -67.30%.
| Gross Margin | 74.00% |
| Operating Margin | -66.82% |
| Pretax Margin | -66.71% |
| Profit Margin | -67.30% |
| EBITDA Margin | -65.04% |
| EBIT Margin | -66.82% |
| FCF Margin | n/a |
Dividends & Yields
Pulmonx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.99% |
| Shareholder Yield | n/a |
| Earnings Yield | -20.78% |
| FCF Yield | -12.15% |
Analyst Forecast
The average price target for Pulmonx is $12.64, which is 94.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.64 |
| Price Target Difference | 94.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 18.18% |
| EPS Growth Forecast (5Y) | -17.51% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pulmonx has an Altman Z-Score of -1.32 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.32 |
| Piotroski F-Score | 4 |